Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Farmers Insurance
Dow
McKesson
Chinese Patent Office
Baxter
Deloitte
UBS

Generated: December 13, 2018

DrugPatentWatch Database Preview

Litigation Details for CIBA Specialty v. Hercules Inc. (D. Del. 2004)

« Back to Dashboard

Small Molecule Drugs cited in CIBA Specialty v. Hercules Inc.
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , and ➤ Try a Free Trial .
Biologic Drugs cited in CIBA Specialty v. Hercules Inc.
The biologic drug covered by the patents cited in this case is ➤ Try a Free Trial .

Details for CIBA Specialty v. Hercules Inc. (D. Del. 2004)

Date Filed Document No. Description Snippet Link To Document
2005-09-27 207 Exhibit A-N ) - At 31 Deccrober 2004 36,656 223,698 8,358 8,188 276,900 M_ nmu md ~.S=" Deprecz'cttxbn At…production processes and this is where Ciba' patented technologies such t the Ciba® TEl..lOFORM® retention…company, including ali expenditure in respect of patents end trademarks1 is written off as incurred Case…2004 27 July 2006 1:04-cv-00293-KAJ Patent District Court, D. Delaware External link to document
2006-01-09 303 Exhibit 9 .6 4,92.5,530 5/1990- Sinclair et a.l. 162/164.6 4,968,435 11/1990 NeH` et a.l. ......................…[11} Patent Number: 5,167,766 [45] Date of Patent: Dec. 1, 1992 [56] References Cited U.S. PATENT DOCUMENTS…That The Accused Performs System Infringes U.S. Patent Nos. 5,167,766 and 5,171,808 (Vol. 1) by CIBA Specialty…EXHIBIT 9 CaSe 1 204-CV-00293-KAJ United States Patent nn Honig et al. Document 303-8 [54] i75]…machine. The latices of the above and following four patent references were made according to U.S. Pat. No. External link to document
2006-01-09 307 Exhibit 12 Part 4 epzt: G. G. Coker, 59 (1983 to Weil-» J.S. pat. 4,501,893 acoltinetics in hu- Fhsrmoeol. 28, 197 , Cnhen…previously submitted to the Patent and Trademark Ol§i:el Th° COMMN§| SlONER op PATENTS AND TRADEMARKS is requested…fxtrthnrcmtmication, m relating to the patent applications and patents identified §§ 133 §!§Ig§§p LI§TL to…Corporation's Motion for Claim Construction of the Patents-in-Suit by CIBA Specialty Chemicals Corporation…lnlormaiitiers are indicated on lhe NO'|'|CE HE PATENT DRAW|NGS, PTO- 948, allached herein or 10 Paper External link to document
2006-06-19 404 Exhibit Exhibit 13 ? 167:2»168:7 204:4~13 170:5»172:10 207:13~208:9 194:11~194:14 Exhibit 13 of the Pretriai Order…2004 27 July 2006 1:04-cv-00293-KAJ Patent District Court, D. Delaware External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Medtronic
Cipla
Queensland Health
Chinese Patent Office
Farmers Insurance
Chubb
Baxter
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.